Audrey Clapéron
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Cancer Mechanisms and Therapy 5
-
- Cell death mechanisms and regulation 3
- Cancer-related gene regulation 3
- RNA modifications and cancer 2
- Melanoma and MAPK Pathways 2
- Co-authors
- Laura Fouassier (13 shared papers)Thanh Huong Nguyen Ho-Bouldoires (6 shared papers)Marc Therrien (1 shared paper)Javier Vaquero (4 shared papers)Chantal Housset (9 shared papers)Valérie Paradis (5 shared papers)Nathalie Guedj (5 shared papers)Martine Mergey (8 shared papers)
- Journals
- Oncogene (4 papers)Journal of Hepatology (3 papers)Molecular Psychiatry (2 papers)Journal of Medicinal Chemistry (2 papers)Free Radical Biology and Medicine (1 paper)
- Partner nations
- FranceGermanyUnited Kingdom
In The Last Decade
Audrey Clapéron
26 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 239
- Oncology 428
- Cell Biology 269
- Hematology 160
- Molecular Biology 929
Countries citing papers authored by Audrey Clapéron
This map shows the geographic impact of Audrey Clapéron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Clapéron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Clapéron more than expected).
Fields of papers citing papers by Audrey Clapéron
This network shows the impact of papers produced by Audrey Clapéron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Clapéron. The network helps show where Audrey Clapéron may publish in the future.
Co-authors
The 25 scholars most cited alongside Audrey Clapéron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 291 | |
| 2 | 2018 | 146 | |
| 3 | 2016 | 133 | |
| 4 | 2007 | 117 | |
| 5 | 2014 | 116 | |
| 6 | 2013 | 107 | |
| 7 | 2018 | 96 | |
| 8 | 2013 | 92 | |
| 9 | 2018 | 89 | |
| 10 | 2020 | 86 | |
| 11 | 2017 | 71 | |
| 12 | 2019 | 59 | |
| 13 | 2004 | 54 | |
| 14 | 2011 | 48 | |
| 15 | S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth | 2018 | 43 |
| 16 | 2009 | 41 | |
| 17 | 2005 | 26 | |
| 18 | 2007 | 23 | |
| 19 | 2015 | 20 | |
| 20 | 2011 | 17 |
About Audrey Clapéron
Audrey Clapéron is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Hematology and Cell Biology, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cell death mechanisms and regulation (3 papers), Cancer-related gene regulation (3 papers), Peptidase Inhibition and Analysis (3 papers), Blood groups and transfusion (2 papers), RNA modifications and cancer (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Cancer Research (239 citations), Oncology (428 citations), Cell Biology (269 citations), Hematology (160 citations) and Molecular Biology (929 citations). Audrey Clapéron has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Laura Fouassier, Thanh Huong Nguyen Ho-Bouldoires, Marc Therrien, Javier Vaquero, Chantal Housset, Valérie Paradis, Nathalie Guedj, Martine Mergey, Dominique Wendum and Christèle Desbois‐Mouthon. Their work appears in journals such as Oncogene, Journal of Hepatology, Molecular Psychiatry, Journal of Medicinal Chemistry and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.